Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 3,040 | 2,519 | 2,208 | 1,862 | 1,533 |
| Cost of Goods | 1,608 | 1,322 | 1,189 | 1,268 | 1,047 |
| Gross Profit | 1,431 | 1,197 | 1,019 | 594 | 486 |
| Operating Expenses | 2,406 | 4,606 | 1,451 | 1,755 | 1,735 |
| Operating Income | -366 | -3,087 | -244 | -893 | -1,202 |
| Interest Expense | 708 | 4,140 | 1,362 | 684 | 773 |
| Other Income | 0 | 2 | -2 | 0 | 0 |
| Pre-tax Income | -1,075 | -7,225 | -1,608 | -1,577 | -1,975 |
| Net Income Continuous | -1,075 | -7,139 | -1,608 | -1,577 | -1,975 |
| Minority Interests | N/A | N/A | 0 | -1 | -25 |
| Net Income | $-1,075 | $-7,139 | $-1,608 | $-1,576 | $-1,950 |
| EPS Basic Total Ops | -0.02 | -0.11 | -0.03 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.12 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.11 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.12 | -0.03 | -0.03 | -0.03 |
| EBITDA(a) | $-88 | $555 | $920 | $-194 | $-924 |